Improving health system care for people with substance use disorders
Health Systems Node of the NIDA Clinical Trials Network
Trying new ways to help adults and young people with substance use get safer, more accessible treatment through health systems.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Kaiser Foundation Research Institute NIH-funded |
| Lab location | 1 site (Oakland, UNITED STATES) |
| Project ID | NIH-11261241 on NIH RePORTER |
What this research studies
As someone affected by substance use, this effort works with health systems to make treatment easier to access and safer. The team runs real-world programs across many clinics to try approaches like nurse care managers, wider use of medications such as buprenorphine, and outreach to people using opioids, stimulants, or cannabis. They use pragmatic, multi-site trials and improved measures to track outcomes and apply statistical methods to learn what works at scale. The goal is to reduce overdoses and increase use of effective care in routine medical settings.
Who could benefit from this research
Good fit: Adults and adolescents with substance use or substance use disorders—including opioid, stimulant, or cannabis use—who receive care in participating health systems are the ideal candidates.
Not a fit: People without substance use problems, or those who do not receive care at participating clinics or health systems, are unlikely to benefit directly from this work.
Why it matters
Potential benefit: Could make it easier for people with substance use disorders to start and stay in effective treatments and reduce overdose deaths.
How similar studies have performed: Previous CTN work has shown nurse care managers and pragmatic trials can increase opioid use disorder treatment, though addressing fentanyl, polysubstance use, and rising cannabis harms remains challenging.
Where this research is happening
Oakland, UNITED STATES
- Kaiser Foundation Research Institute — Oakland, United States (Active)
Researchers
- Principal investigator: Campbell, Cynthia I — Kaiser Foundation Research Institute
- Study coordinator: Campbell, Cynthia I
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.